Business Context and Reporting Period
Company: uniQure N.V.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: April 4, 2016
Reporting Period: Fourth Quarter and Full Year 2015
This filing serves as a cover document for a press release (Exhibit 99.1) announcing the company's financial results for the fourth quarter and the full fiscal year 2015. The registrant files annual reports under Form 20-F.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The filing references a press release for the actual figures but does not include them within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus prior periods. It only indicates that results for the fourth quarter and full year 2015 are announced in the attached press release.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in this specific filing text. These details are contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 4, 2016) for actual revenue, net loss, and cash position figures.
- Verify the specific clinical trial progress or regulatory updates mentioned in the full press release, as this filing only announces the results.
- Confirm the company's liquidity status and burn rate from the full financial statements referenced in the press release.
- Check for any updated guidance for 2016 provided in the full announcement.